The effect by which hormonal contraceptives are thought to influence breast cancer risk could be due to direct stimulatory action on breast tissue, for instance, via cross regulatory signalling networks between the estrogen receptor (ER) α and BRCA1,27 or indirectly via delayed childbirth and lower parity. The gene discussed is ESR1; the disease is breast cancer.